Literature DB >> 33363666

ADRENOCORTICOTROPIC HORMONE IMMUNOASSAY INTERFERENCE IN A PATIENT WITH SUBCLINICAL HYPERCORTISOLISM.

B Ozgen Saydam1, S C Adiyaman1, L Demir2, S Yener1.   

Abstract

CONTEXT: Immunoassays are vulnerable to occasional analytical errors despite their sensitivity and specificity. Adrenocorticotropic hormone (ACTH) is among hormones which are vulnerable to assay interference.
OBJECTIVE: In this case report, we aimed to present a case of ACTH interference in a patient with subclinical hypercortisolism. CASE REPORT: We present a case of subclinical hypercortisolism with unexpectedly elevated levels of ACTH in whom interference was shown by different biochemical methods.It is important for the clinician to keep in mind the possibility of interference when clinical and laboratory results are discordant. The communication between the clinician and laboratory staff is important while interpreting results. This case report shows that ACTH interference should be considered in patients with subclinical hypercortisolism who have unexpectedly high levels of adrenocorticotropic hormone. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  ACTH interference; Adrenocorticotropic hormone; subclinical hypercortisolism

Year:  2020        PMID: 33363666      PMCID: PMC7748235          DOI: 10.4183/aeb.2020.379

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  16 in total

Review 1.  Unusual results from immunoassays and the role of the clinical endocrinologist.

Authors:  Alison M Jones; John W Honour
Journal:  Clin Endocrinol (Oxf)       Date:  2006-03       Impact factor: 3.478

Review 2.  Heterophilic antibody interference in immunometric assays.

Authors:  Nils Bolstad; David J Warren; Kjell Nustad
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-06-20       Impact factor: 4.690

Review 3.  Calcitonin measurement and immunoassay interference: a case report and literature review.

Authors:  Simona Censi; Elisabetta Cavedon; Sara Watutantrige Fernando; Susi Barollo; Loris Bertazza; Laura Zambonin; Martina Zaninotto; Diego Faggian; Mario Plebani; Caterina Mian
Journal:  Clin Chem Lab Med       Date:  2016-12-01       Impact factor: 3.694

4.  Assessment of ACTH assay variability: a multicenter study.

Authors:  Francesca Pecori Giraldi; Andrea Saccani; Francesco Cavagnini
Journal:  Eur J Endocrinol       Date:  2011-01-20       Impact factor: 6.664

5.  Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.

Authors:  Serkan Yener; Leyla Demir; Mustafa Demirpence; Mustafa Mahmut Baris; Ilgin Yildirim Simsir; Secil Ozisik; Abdurrahman Comlekci; Tevfik Demir
Journal:  Endocrine       Date:  2017-02-28       Impact factor: 3.633

6.  A Case With Immunoassay Interferences in the Measurement of Multiple Hormones.

Authors:  Ozlem Gulbahar; Ceyla Konca Degertekin; Mujde Akturk; Mehmet Muhittin Yalcin; Isilay Kalan; Gokce Filiz Atikeler; Alev Eroglu Altinova; Ilhan Yetkin; Metin Arslan; Fusun Toruner
Journal:  J Clin Endocrinol Metab       Date:  2015-04-21       Impact factor: 5.958

7.  Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  C Invitti; F Pecori Giraldi; M de Martin; F Cavagnini
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

Review 8.  ACTH-independent macronodular adrenal hyperplasia.

Authors:  André Lacroix
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-04       Impact factor: 4.690

Review 9.  Nonfunctioning pituitary tumors and pituitary incidentalomas.

Authors:  Mark E Molitch
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

Review 10.  Subclinical Hypercortisolism: How to Deal with It?

Authors:  Iacopo Chiodini; Valentina Morelli
Journal:  Front Horm Res       Date:  2016-05-17       Impact factor: 2.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.